Abstract 10709: Extended Survival and Re-Hospitalization for Pediatric Patients Requiring Extracorporeal Membrane Oxygenation for Primary Cardiac Dysfunction
Objectives: To determine survival to hospital discharge, extended survival, and re-hospitalization rates for children requiring extracorporeal membrane oxygenation (ECMO) support for medical and surgical cardiac failure.
Study Design: Retrospective review of all pediatric patients receiving ECMO for primary cardiac dysfunction over a 5 year period at our institution. Data include the initial hospital course, re-hospitalizations and extended survival.
Results: Sixty-eight patients (74 ECMO runs) were identified with a median follow-up of 5.4 years from hospital discharge. Overall, 66% of patients were decannulated alive and 37% (n=25) survived to discharge. There were three late-deaths occurring at 5 months, 20 months, and 6.8 years from discharge. Eighty-eight percent of hospital survivors required re-hospitalization, with 63% of readmissions were for cardiac indications respectively. The mean number of hospitalizations per patient per year was 1.5, with first re-admission occurring at a mean time of 9 months post discharge from index hospitalization. Thirty-eight percent of patients required further cardiac surgery.
Conclusions: Extended survival for pediatric hospital survivors of cardiac ECMO support for medical and post-surgical indications is encouraging. However, re-hospitalization within the first year following hospital discharge is very common, and many patients require further cardiac surgery. While re-admission hospital mortality is low, many patients will require further cardiac surgery and long-term follow up.
- © 2011 by American Heart Association, Inc.